Advanced search
Publication Cover
Aging Health Volume 4, 2008 - Issue 4
Journal homepage
449
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Role of Screening in Managing Osteoporosis in Men

W P OlszynskiUniversity of Saskatchewan, Suite103, 39–23rd Street East, Saskatoon, S7K 0H6, Canada. [email protected]View further author information
Pages 329-331 | Published online: 04 Aug 2008

Bibliography

  • Kiebzak GM , BeinartGA, PerserK, AmbroseCG, SiffSJ, HeggenessMH: Undertreatment of osteoporosis in men with hip fracture.Arch. Intern. Med.162(19), 2217–2222(2002).
  • Morris CA , CabralD, ChengHet al.: Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J. Gen. Intern. Med.19(7), 783–790(2004).
  • Nguyen TV , EismanJA, KellyPJ, Sambrook PN: Risk factors for osteoporotic fractures in elderly men. Am. J. Epidemiol.144(3), 255–263(1996).
  • Fransen M , WoodwardM, NortonR, RobinsonE, ButlerM, CampbellAJ: Excess mortality or institutionalization after hip fracture: men are at greater risk than women.J. Am. Geriatr. Soc.50(4), 685–690(2002).
  • Johnell O , KanisJA, OdenAet al.: Predictive value of BMD for hip and other fractures. J. Bone Miner. Res.20(7), 1185–1194(2005).
  • Neer RM , ArnaudCD, ZanchettaJRet al.: Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med.344(19), 1434–1441(2001).
  • Black DM , CummingsSR, KarpfDBet al.: Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet348(9041), 1535–1541(1996).
  • Black DM , DelmasPD, EastellRet al.: Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N. Engl. J. Med.356(18), 1809–1822(2007).
  • Cummings SR , BlackDM, ThompsonDEet al.: Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA280(24), 2077–2082(1998).
  • Meunier PJ , RouxC, SeemanEet al.: The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N. Engl. J. Med.350(5), 459–468(2004).
  • Lyles KW , Colon-EmericCS, MagazinerJSet al.: Zoledronic acid in reducing clinical fracture and mortality after hip fracture. N. Engl. J. Med.357, nihpa40967 (2007).
  • McClung MR , GeusensP, MillerPDet al.: Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N. Engl. J. Med.344(5), 333–340(2001).
  • MacLean C , NewberryS, MaglioneMet al.: Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann. Intern. Med.148(3), 197–213(2008).
  • Siris ES , ChenYT, AbbottTAet al.: Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch. Intern. Med.164(10), 1108–1112(2004).
  • Schuit SC , van der KM, Weel AE et al.: Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone34(1), 195–202(2004).
  • Liu H , PaigeNM, GoldzweigCLet al.: Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline. Ann. Intern. Med.148(9), 685–701(2008).
  • Qaseem A , SnowV, ShekelleP, Hopkins R Jr, Forciea MA, Owens DK: Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med.148(9), 680–684(2008).
  • Shepherd AJ , CassAR, CarlsonCA, RayL: Development and internal validation of the male osteoporosis risk estimation score.Ann. Fam. Med.5(6), 540–546(2007).
  • Berger C , LangsetmoL, JosephLet al.: Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. Can. Med. Asso. J.178(13), 1660–1668(2008).
  • Schousboe JT , TaylorBC, FinkHAet al.: Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA298(6), 629–637(2007).
  • Kulmala J , SihvonenS, KallinenM, Alen M, Kiviranta I, Sipila S: Balance confidence and functional balance in relation to falls in older persons with hip fracture history. J. Geriatr. Phys. Ther.30(3), 114–120(2007).
  • Hartikainen S , LonnroosE, LouhivuoriK: Medication as a risk factor for falls: critical systematic review.J. Gerontol. A Biol. Sci. Med. Sci.62(10), 1172–1181(2007).
  • van Helden S , WyersCE, DagneliePCet al.: Risk of falling in patients with a recent fracture. BMC Musculoskelet. Disord.8, 55 (2007).
  • Kanis JA , JohnellO, De Laet C et al.: A meta-analysis of previous fracture and subsequent fracture risk. Bone35(2), 375–382(2004).
  • Bessette L , Ste-MarieLG, JeanSet al.: The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos. Int.19(1), 79–86(2008).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.